These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 17963805

  • 1. Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment.
    Musa AM, Khalil EA, Mahgoub FA, Elgawi SH, Modabber F, Elkadaru AE, Aboud MH, Noazin S, Ghalib HW, El-Hassan AM, Leishmaniasis Research Group/Sudan.
    Trans R Soc Trop Med Hyg; 2008 Jan; 102(1):58-63. PubMed ID: 17963805
    [Abstract] [Full Text] [Related]

  • 2. A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis.
    Ramesh V, Kumar J, Kumar D, Salotra P.
    Indian J Dermatol Venereol Leprol; 2010 Jan; 76(2):138-44. PubMed ID: 20228542
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Safety and immunogenicity of an autoclaved Leishmania major vaccine.
    Khalil EA, Elhassan AM, Zijlstra EE, Osman OF, Eljack IA, Ibrahim ME, Mukhtar MM, Ghalib HW, Modabbers F.
    East Afr Med J; 2000 Sep; 77(9):468-70. PubMed ID: 12862135
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
    Khalil EA, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, Elhassan IM, Smith PG, Kieny PM, Ghalib HW, Zicker F, Modabber F, Elhassan AM.
    Clin Exp Immunol; 2005 May; 140(2):349-53. PubMed ID: 15807861
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL).
    Musa AM, Khalil EA, Mahgoub FA, Hamad S, Elkadaru AM, El Hassan AM.
    Ann Trop Med Parasitol; 2005 Sep; 99(6):563-9. PubMed ID: 16156969
    [Abstract] [Full Text] [Related]

  • 8. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
    Moore E, O'Flaherty D, Heuvelmans H, Seaman J, Veeken H, de Wit S, Davidson RN.
    Bull World Health Organ; 2001 Sep; 79(5):388-93. PubMed ID: 11417033
    [Abstract] [Full Text] [Related]

  • 9. Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.
    Atia AM, Mumina A, Tayler-Smith K, Boulle P, Alcoba G, Elhag MS, Alnour M, Shah S, Chappuis F, van Griensven J, Zachariah R.
    Trop Med Int Health; 2015 Dec; 20(12):1674-84. PubMed ID: 26427033
    [Abstract] [Full Text] [Related]

  • 10. Interferon (IFN)-gamma , tumor necrosis factor-alpha , interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis.
    Ansari NA, Ramesh V, Salotra P.
    J Infect Dis; 2006 Oct 01; 194(7):958-65. PubMed ID: 16960784
    [Abstract] [Full Text] [Related]

  • 11. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P, Koirala S, Parija SC, Sethi M, Das ML.
    Southeast Asian J Trop Med Public Health; 2003 Mar 01; 34(1):22-3. PubMed ID: 12971510
    [Abstract] [Full Text] [Related]

  • 12. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.
    Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, Ibrahim ME, Kamil AA, Elsheikh M, Babiker A, Modabber F.
    Lancet; 2000 Nov 04; 356(9241):1565-9. PubMed ID: 11075771
    [Abstract] [Full Text] [Related]

  • 13. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection.
    Ritmeijer K, Dejenie A, Assefa Y, Hundie TB, Mesure J, Boots G, den Boer M, Davidson RN.
    Clin Infect Dis; 2006 Aug 01; 43(3):357-64. PubMed ID: 16804852
    [Abstract] [Full Text] [Related]

  • 14. Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.
    Kamil AA, Khalil EA, Musa AM, Modabber F, Mukhtar MM, Ibrahim ME, Zijlstra EE, Sacks D, Smith PG, Zicker F, El-Hassan AM.
    Trans R Soc Trop Med Hyg; 2003 Aug 01; 97(3):365-8. PubMed ID: 15228261
    [Abstract] [Full Text] [Related]

  • 15. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
    El-Sayed M, Anwar AE.
    J Eur Acad Dermatol Venereol; 2010 Mar 01; 24(3):335-40. PubMed ID: 19744259
    [Abstract] [Full Text] [Related]

  • 16. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
    Zijlstra EE, Khalil EA, Kager PA, El-Hassan AM.
    Br J Dermatol; 2000 Jul 01; 143(1):136-43. PubMed ID: 10886148
    [Abstract] [Full Text] [Related]

  • 17. Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis.
    Ganguly S, Das NK, Panja M, Pal S, Modak D, Rahaman M, Mallik S, Guha SK, Pramanik N, Goswami R, Barbhuiya JN, Saha B, Chatterjee M.
    J Infect Dis; 2008 Jun 15; 197(12):1762-71. PubMed ID: 18444882
    [Abstract] [Full Text] [Related]

  • 18. Elevated levels of interferon-gamma, interleukin-10, and interleukin-6 during active disease in Indian kala azar.
    Ansari NA, Saluja S, Salotra P.
    Clin Immunol; 2006 Jun 15; 119(3):339-45. PubMed ID: 16540374
    [Abstract] [Full Text] [Related]

  • 19. Expression profiling of Sudanese visceral leishmaniasis patients pre- and post-treatment with sodium stibogluconate.
    Salih MAM, Fakiola M, Lyons PA, Younis BM, Musa AM, Elhassan AM, Anderson D, Syn G, Ibrahim ME, Blackwell JM, Mohamed HS.
    Parasite Immunol; 2017 Jun 15; 39(6):. PubMed ID: 28370072
    [Abstract] [Full Text] [Related]

  • 20. Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice.
    Joshi J, Kaur S.
    Parasitology; 2014 Apr 15; 141(4):554-62. PubMed ID: 24618257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.